Xingming Zhang

West China Hospital, Sichuan University

Xingming Zhang, MD/PhD, from the Department of Urology at West China Hospital, Sichuan University, is dedicated to the scientific research and clinical practice of urological tumors, with a focus on renal cell carcinoma (especially non-ccRCC) and prostate cancer. To date, I have published over 50 academic papers, including Genome Medicine, Clin Cancer Res, the Faseb journal, Prostate, Asian J Androl, Neoplasia, J Cancer, etc.

Disclosure information not submitted.

Presentation(s):

• MP17-20: Epigenetic regulator KMT2C mutation detected by liquid biopsy is associated with worse survival in prostate cancer patients

  Friday, April 28, 2023
  1:00 PM – 3:00 PM CST

• PD24-09: Phase II, Multi-center Study of Sintilimab in Combination with Axitinib in Patients with Advanced Fumarate Hydratase-deficient Renal Cell Carcinoma

  Sunday, April 30, 2023
  8:20 AM – 8:30 AM CST